BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Brayette A, Essig M, Carrier P, Debette-Gratien M, Labrunie A, Alain S, Maynard M, Ganne-Carrié N, Nguyen-Khac E, Pinet P, De Ledinghen V, Renou C, Mathurin P, Vanlemmens C, Di Martino V, Gervais A, Foucher J, Isabelle FH, Vergniol J, Hourmand-Ollivier I, Cohen D, Duval X, Poynard T, Bardou M, Abergel A, Dao MT, Thévenot T, Hiriart JB, Canva V, Lassailly G, Aurières C, Boyer N, Thabut D, Bernard PH, Schnee M, Larrey D, Hanslik B, Hommel S, Jacques J, Loustaud-Ratti V. Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus. World J Hepatol 2020; 12(12): 1326-1340 [PMID: 33442458 DOI: 10.4254/wjh.v12.i12.1326]
URL: https://www.wjgnet.com/1007-9327/full/v12/i12/1326.htm
Number Citing Articles
1
Chiara Masetti, Nicola Pugliese, Alessio Aghemo, Mauro Viganò. Safety of current antiviral drugs for chronic hepatitis BExpert Opinion on Drug Safety 2022; 21(7): 939 doi: 10.1080/14740338.2022.2045271
2
Xuan Li, Qiang Wu, Fang Huang, Changxiang Lai, Fengjuan Chen, Juan Meng, Fang Wang, Hui Zeng, Lina Zhang. Longitudinal changes in estimated glomerular filtration rates in chronic hepatitis B patients treated with Tenofovir Alafenamide vs EntecavirPeerJ 2025; 13: e19901 doi: 10.7717/peerj.19901
3
Andinet Gizaw, Wendy C. King, Amanda S. Hinerman, Raymond T. Chung, Mauricio Lisker‐Melman, Marc G. Ghany, Mandana Khalili, Mamta K. Jain, Jacob Graham, Theresa Swift‐Scanlan, David E. Kleiner, Mark Sulkowski, David K. Wong, Richard K. Sterling. A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)‐HIV co‐infection with high prevalence of tenofovir‐based antiretroviral therapy useHIV Medicine 2023; 24(1): 55 doi: 10.1111/hiv.13322